BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6297436)

  • 1. Effects of synthetic muramyl dipeptide on bone metabolism in the fetal rat.
    Dziak R; Rowe DJ; Brown MJ; Hausmann E
    Arch Oral Biol; 1982; 27(10):787-91. PubMed ID: 6297436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture.
    Dewhirst FE
    Infect Immun; 1982 Jan; 35(1):133-7. PubMed ID: 7054120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of two bacterial products, muramyl dipeptide and endotoxin, on bone resorption in organ culture.
    Raisz LG; Alander C; Eilon G; Whitehead SP; Nuki K
    Calcif Tissue Int; 1982 Jul; 34(4):365-9. PubMed ID: 6291730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin effects on isolated bone cells.
    Shlossman M; Brown M; Shapiro E; Dziak R
    Calcif Tissue Int; 1982 Mar; 34(2):190-6. PubMed ID: 6282413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muramyl dipeptide enhances lipopolysaccharide-induced osteoclast formation and bone resorption through increased RANKL expression in stromal cells.
    Ishida M; Kitaura H; Kimura K; Sugisawa H; Aonuma T; Takada H; Takano-Yamamoto T
    J Immunol Res; 2015; 2015():132765. PubMed ID: 26000311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
    Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
    J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cholera toxin on cyclic AMP accumulation and bone resorption in cultured mouse calvaria.
    Ransjö M; Lerner UH
    Biochim Biophys Acta; 1987 Oct; 930(3):378-91. PubMed ID: 2820504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of lipopolysaccharide from bacteroides gingivalis and muramyl dipeptide on osteoblast collagenase release.
    Sismey-Durrant HJ; Atkinson SJ; Hopps RM; Heath JK
    Calcif Tissue Int; 1989 May; 44(5):361-3. PubMed ID: 2540890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones.
    Lorenzo JA; Raisz LG; Hock JM
    J Clin Invest; 1983 Dec; 72(6):1924-9. PubMed ID: 6643680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation of drugs in rats treated with a synthetic muramyl dipeptide, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP).
    Zídek Z; Kameníková L; Buchar E; Janků I; Masek K
    Int J Immunopharmacol; 1983; 5(2):151-5. PubMed ID: 6874168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protection from hepatotoxicity of some compounds by the synthetic immunomodulator muramyl dipeptide (MDP) in rat hepatocytes and in vivo.
    Farghali H; Machková Z; Kameníková L; Jankü I; Masek K
    Methods Find Exp Clin Pharmacol; 1984 Aug; 6(8):449-54. PubMed ID: 6492941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzo(B)thiophene-2-carboxylic acid: calcium uptake and cyclic AMP production in isolated bone cells.
    Robin JC; Brown MJ; Weinfeld N; Dziak RM
    Calcif Tissue Int; 1984 Mar; 36(2):194-9. PubMed ID: 6331614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Muramyl Dipeptide in Lipopolysaccharide-Mediated Biological Activity and Osteoclast Activity.
    Kitaura H; Ishida M; Kimura K; Sugisawa H; Kishikawa A; Shima K; Ogawa S; Qi J; Shen WR
    Anal Cell Pathol (Amst); 2018; 2018():8047610. PubMed ID: 29666781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analyses of osteoclast changes in resorbing bone organ cultures.
    Rowe DJ; Hausmann E
    Calcif Tissue Res; 1977 Oct; 23(3):283-9. PubMed ID: 902146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of forskolin to study the relationship between cyclic AMP formation and bone resorption in vitro.
    Lerner UH; Fredholm BB; Ransjö M
    Biochem J; 1986 Dec; 240(2):529-39. PubMed ID: 3028378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic mixed-function oxidase system and microsomal lipid peroxidation in rats treated with a synthetic immunomodulator, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP).
    Yanev S; Zídek Z; Kadiiska M; Serbinova E; Masek K; Stoytchev T
    Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):311-5. PubMed ID: 6748821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoblast and osteoclast precursors in primary cultures of calvarial bone cells.
    Burger EH; Boonekamp PM; Nijweide PJ
    Anat Rec; 1986 Jan; 214(1):32-40. PubMed ID: 3954057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muramyl dipeptide and sleep in rat.
    Kadlecová O; Masek K
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):111-5. PubMed ID: 3713371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the role of cyclic AMP as a mediator of bone resorption: gamma-interferon completely inhibits cholera toxin- and forskolin-induced but only partially inhibits parathyroid hormone-stimulated 45Ca release from mouse calvarial bones.
    Lerner UH; Ransjö M; Ljunggren O; Klaushofer K; Hoffmann O; Peterlik M
    J Bone Miner Res; 1991 Jun; 6(6):551-60. PubMed ID: 1653515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.